Antianxiety drugs and its effect on psychomotor performance

Acute effect of Anti-anxiety drugs on psychomotor performance in healthy volunteers: A Prospective, crossover study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010301

Enrollment

Registered

2017-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Venlafaxine: Cap Venlafaxine (37.5 mg) ORAL single dose Control Intervention1: Alprazolam : Tab Alprazolam (0.5 mg) ORAL single dose Control Intervention2: Escitalopram: Tab Escitalop

Eligibility

Inclusion criteria

Inclusion criteria: 1)Healthy volunteers 2)with minimum education upto secondary school certificate

Exclusion criteria

Exclusion criteria: 1)H/o of bleeding disorders 2)H/o Hypertension 3)H/o Smoking 4)H/o Alcoholism 5)H/o Seizures 6)H/o allergy, hypersensitivity or reaction to any medication 7)H/o receiving chronic medication for any type of illness 8)H/o decreased visual acuity without correction 9)Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To evaluate effects of Alprazolam, Escitalopram & Venlafaxine on psychomotor performance in healthy volunteers with the help of battery of the subjective and objective psychomotor tests Timepoint: 0 hour 2 hours 4 hours	—

Secondary

Measure	Time frame
To compare the effects of these drugs on psychomotor performance & To study any other side effects of the drugs Timepoint: 0 hour 2 hours 4 hours	—

Countries

India

Contacts

Public ContactDr Ankita Sunilrao Jire

GMC,Nagpur

chaitali_bajait@yahoo.com8999905594

Outcome results